National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           
Last Modified: 4/30/2008     First Published: 8/14/2007  

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


Other, Pharmaceutical / Industry


WCTU-FRAGMATIC
Velindre-FRAGMATIC, WCTU-02, EU-20753, WCTU-02, PFIZER-WCTU-02, WCTU-FRAGMATIC, EUDRACT-2005-002438-37, ISRCTN80812769, NCT00519805

Last Modified: 1/13/2009     First Published: 4/17/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Biomarker/Laboratory analysis, Supportive care, Treatment


Active


18 to 80


Other, Pharmaceutical / Industry


GERCOR-PAM07-D07-2
GERCOR-PAM07-D07-2, EUDRACT 2007-002115-59, EU-20837, PFIZER-GERCOR-PAM07-D07-2, NCT00662688

Last Modified: 4/25/2007     First Published: 4/13/2007  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Supportive care, Treatment


Active


18 and over


Other, Pharmaceutical / Industry


PRH-HCTU-FRAGEM
PRH-HCTU-FRAGEM-V-12.1, CTA-MF8000/13558, EU-20721, LILLY-PRH-HCTU-FRAGEM, FRAGEM, ISRCTN76464767, NCT00462852


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Supportive care


Active


30 and over


Other


2004-0743
NCT00525057

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov